188 related articles for article (PubMed ID: 2269579)
1. Receptor and postreceptor effects of free fatty acids (FFA) on hepatocyte insulin dynamics.
Hennes MM; Shrago E; Kissebah AH
Int J Obes; 1990 Oct; 14(10):831-41. PubMed ID: 2269579
[TBL] [Abstract][Full Text] [Related]
2. New discoveries in obesity: an introduction to the NAASO 1989 Ethan Sims Young Investigator award.
Hirsch J
Int J Obes; 1990 Oct; 14(10):829-30. PubMed ID: 2269578
[No Abstract] [Full Text] [Related]
3. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
Groop LC; Saloranta C; Shank M; Bonadonna RC; Ferrannini E; DeFronzo RA
J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032
[TBL] [Abstract][Full Text] [Related]
4. Saturated fatty acids inhibit hepatic insulin action by modulating insulin receptor expression and post-receptor signalling.
Ruddock MW; Stein A; Landaker E; Park J; Cooksey RC; McClain D; Patti ME
J Biochem; 2008 Nov; 144(5):599-607. PubMed ID: 18713797
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of free fatty acid effects on hepatocyte insulin receptor binding and processing.
Hennes MM; Shrago E; Kissebah AH
Obes Res; 1993 Jan; 1(1):18-28. PubMed ID: 16353347
[TBL] [Abstract][Full Text] [Related]
6. Role of fatty acid binding protein on hepatic palmitate uptake.
Burczynski FJ; Zhang MN; Pavletic P; Wang GQ
Can J Physiol Pharmacol; 1997 Dec; 75(12):1350-5. PubMed ID: 9534945
[TBL] [Abstract][Full Text] [Related]
7. Effect of free fatty acids on insulin receptor binding and tyrosine kinase activity in hepatocytes isolated from lean and obese rats.
Svedberg J; Björntorp P; Smith U; Lönnroth P
Diabetes; 1992 Mar; 41(3):294-8. PubMed ID: 1312964
[TBL] [Abstract][Full Text] [Related]
8. Weight reduction and the impaired plasma-derived free fatty acid oxidation in type 2 diabetic subjects.
Blaak EE; Wolffenbuttel BH; Saris WH; Pelsers MM; Wagenmakers AJ
J Clin Endocrinol Metab; 2001 Apr; 86(4):1638-44. PubMed ID: 11297597
[TBL] [Abstract][Full Text] [Related]
9. Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle.
Blaak EE; Wagenmakers AJ; Glatz JF; Wolffenbuttel BH; Kemerink GJ; Langenberg CJ; Heidendal GA; Saris WH
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E146-54. PubMed ID: 10893334
[TBL] [Abstract][Full Text] [Related]
10. Regulation of hepatic free fatty acid metabolism by glucagon and insulin.
Witters LA; Trasko CS
Am J Physiol; 1979 Jul; 237(1):E23-9. PubMed ID: 157075
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in long chain fatty acid utilization and fatty acid binding protein concentration in rat liver.
Ockner RK; Burnett DA; Lysenko N; Manning JA
J Clin Invest; 1979 Jul; 64(1):172-81. PubMed ID: 447853
[TBL] [Abstract][Full Text] [Related]
12. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction.
Boden G; Shulman GI
Eur J Clin Invest; 2002 Jun; 32 Suppl 3():14-23. PubMed ID: 12028371
[TBL] [Abstract][Full Text] [Related]
13. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.
Groop LC; Bonadonna RC; DelPrato S; Ratheiser K; Zyck K; Ferrannini E; DeFronzo RA
J Clin Invest; 1989 Jul; 84(1):205-13. PubMed ID: 2661589
[TBL] [Abstract][Full Text] [Related]
14. Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta.
Lam TK; Yoshii H; Haber CA; Bogdanovic E; Lam L; Fantus IG; Giacca A
Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E682-91. PubMed ID: 12217885
[TBL] [Abstract][Full Text] [Related]
15. Fatty acids in the portal vein of the rat regulate hepatic insulin clearance.
Svedberg J; Strömblad G; Wirth A; Smith U; Björntorp P
J Clin Invest; 1991 Dec; 88(6):2054-8. PubMed ID: 1752963
[TBL] [Abstract][Full Text] [Related]
16. Endurance training increases FFA oxidation and reduces triacylglycerol utilization in contracting rat soleus.
Dyck DJ; Miskovic D; Code L; Luiken JJ; Bonen A
Am J Physiol Endocrinol Metab; 2000 May; 278(5):E778-85. PubMed ID: 10780932
[TBL] [Abstract][Full Text] [Related]
17. Impaired fatty acid oxidation in muscle of aging rats perfused under basal conditions.
Tucker MZ; Turcotte LP
Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1102-9. PubMed ID: 11934676
[TBL] [Abstract][Full Text] [Related]
18. Fasting nonesterified fatty acid profiles in childhood and their relationship with adiposity, insulin sensitivity, and lipid levels.
Sabin MA; De Hora M; Holly JM; Hunt LP; Ford AL; Williams SR; Baker JS; Retallick CJ; Crowne EC; Shield JP
Pediatrics; 2007 Dec; 120(6):e1426-33. PubMed ID: 18055661
[TBL] [Abstract][Full Text] [Related]
19. The lowering of hepatic fatty acid uptake improves liver function and insulin sensitivity without affecting hepatic fat content in humans.
Rigazio S; Lehto HR; Tuunanen H; Någren K; Kankaanpaa M; Simi C; Borra R; Naum AG; Parkkola R; Knuuti J; Nuutila P; Iozzo P
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E413-9. PubMed ID: 18505832
[TBL] [Abstract][Full Text] [Related]
20. Pubescence-related changes in hepatocyte insulin dynamics in female rats.
Krakower GR; Kissebah AH
Am J Physiol; 1989 Jun; 256(6 Pt 1):E780-7. PubMed ID: 2660589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
